Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

Skinvisible (SKVI) Change in Receivables (2016 - 2025)

Skinvisible (SKVI) has disclosed Change in Receivables for 14 consecutive years, with $4530.0 as the latest value for Q1 2025.

  • Quarterly Change in Receivables changed N/A to $4530.0 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was -$9543.0 through Mar 2025, changed N/A year-over-year, with the annual reading at -$18991.0 for FY2022, 348.7% down from the prior year.
  • Change in Receivables hit $4530.0 in Q1 2025 for Skinvisible, up from -$14073.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $4966.0 in Q4 2021 to a low of -$14073.0 in Q4 2022.
  • Historically, Change in Receivables has averaged -$853.12 across 3 years, with a median of $726.0 in 2021.
  • Biggest five-year swings in Change in Receivables: skyrocketed 106.03% in 2021 and later tumbled 506.16% in 2022.
  • Year by year, Change in Receivables stood at $4966.0 in 2021, then crashed by 383.39% to -$14073.0 in 2022, then soared by 132.19% to $4530.0 in 2025.
  • Business Quant data shows Change in Receivables for SKVI at $4530.0 in Q1 2025, -$14073.0 in Q4 2022, and $29.0 in Q2 2022.